Peter Dudek - President & Managing Partner, MRL Ventures Fund @ Merck

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Peter Dudek is a partner MRL Ventures Fund at Merck.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Carisma Therapeutics	MRL Ventures Fund	—	Series C - Carisma Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Mozart Therapeutics	MRL Ventures Fund	—	Series A - Mozart Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Carisma Therapeutics	MRL Ventures Fund	—	Series B - Carisma Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Xilio Therapeutics	MRL Ventures Fund	—	Series C - Xilio Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Xilio Therapeutics	MRL Ventures Fund	—	Series B - Xilio Therapeutics	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

has

current jobs as

President & Managing Partner, MRL Ventures Fund

and

Partner

. Additionally,

has had

past job as the

Associate

Organization Name	Title At Company	Start Date	End Date
Entrepreneurs Fund	Associate	May 2011	Jan 2016

Number of Current Board & Advisor Roles

holds

board and advisor roles as

Board Member

and

Board of Director

Hub Name	CB Rank (Hub)
United States Pharmaceutical Companies (Top 10K)	3,251
Companies that Went Public in 1980	86,072
East Coast Public Companies With More Than $50M in Revenue	5,756
Companies That Exited in 1980	84,572
Northeastern US Public Companies With More Than 1000 Employees	5,480
Pharmaceutical Public Companies With More Than $1B in Revenue	24,821
Pharmaceutical Companies With More Than $500 in Revenue	10,095
United States Pharmaceutical Public Companies	28,021
Medical Companies With More Than $50M in Revenue	3,524
Biotechnology Public Companies With More Than 50 Employees	7,730